The establishment of an Institute of Pharmacy managing body. The Pharmaceutical Society of Ireland ("PSI") is the statutory body established under the Pharmacy Act, 2007 charged with the regulation of the pharmacy sector in Ireland. It acts in the public interest to regulate the profession. A core function of the PSI includes the requirement to promote and ensure a high standard of education and training for persons seeking to become pharmacists and that those persons and pharmacists obtain appropriate experience and to ensure that pharmacists undertake appropriate continuing professional development, including the acquisition of specialisation. One of the PSI's main duties is the accreditation of education regimes for pharmacists, both prior to and post-registration. A further key duty is the requirement to take suitable action to improve the profession of pharmacy. PSI recently commissioned studies to review the 5 year programme of education and training required to qualify as a pharmacist and the associated accreditation system (in August 2008) and to review international Continuing Professional Development (CPD) models to determine an appropriate system of CPD for pharmacists in Ireland (in January 2009). The PSI now wishes to proceed with the implementation of these recommendations to ensure a competency based approach to development that extends across both pre-registration and ongoing registration systems. With regard to the latter, the CPD review recommends the establishment of "an Institute overseeing the management and delivery of CPD, funding and supporting appropriate provision and ensuring outcomes are generated by providers and assessing the practice standards of pharmacists". The Institute will also be required to contribute to the PSI's core duty of taking suitable action to improve the profession of pharmacy. As foreseen in the Pharmacy Act 2007 and to implement the recommendations contained in the interim report of the Pharmacy Ireland 2020 sub-committee of the PSI Council. In order to manage the implementation and on-going management of the CPD programme allied with the development of pharmacy services, the PSI requires the establishment of this Institute. It is also intended that the contract will include the appointment of an Institute Executive Director to manage the Institute overall and a Director of Pharmacy Practice Development to oversee the development of pharmacy services. Further details can be found in the expression of interest document on www.etenders.gov.ie. A copy of all above mentioned reports is available on the PSI website at www.pharmaceuticalsociety.ie. To register your interest in this notice and obtain any additional information please visit the eTenders web site at http://www.etenders.gov.ie/Search/Search_Switch.aspx?ID=171932.
Deadline
The time limit for receipt of tenders was 2010-12-21.
The procurement was published on 2010-11-23.
Contract notice (2010-11-19) Object Scope of the procurement
Title: Business and management consultancy and related services
Full text:
The establishment of an Institute of Pharmacy managing body. The Pharmaceutical Society of Ireland ("PSI") is the statutory body established under the Pharmacy Act, 2007 charged with the regulation of the pharmacy sector in Ireland. It acts in the public interest to regulate the profession. A core function of the PSI includes the requirement to promote and ensure a high standard of education and training for persons seeking to become pharmacists and that those persons and pharmacists obtain appropriate experience and to ensure that pharmacists undertake appropriate continuing professional development, including the acquisition of specialisation. One of the PSI's main duties is the accreditation of education regimes for pharmacists, both prior to and post-registration. A further key duty is the requirement to take suitable action to improve the profession of pharmacy. PSI recently commissioned studies to review the 5 year programme of education and training required to qualify as a pharmacist and the associated accreditation system (in August 2008) and to review international Continuing Professional Development (CPD) models to determine an appropriate system of CPD for pharmacists in Ireland (in January 2009). The PSI now wishes to proceed with the implementation of these recommendations to ensure a competency based approach to development that extends across both pre-registration and ongoing registration systems. With regard to the latter, the CPD review recommends the establishment of "an Institute overseeing the management and delivery of CPD, funding and supporting appropriate provision and ensuring outcomes are generated by providers and assessing the practice standards of pharmacists". The Institute will also be required to contribute to the PSI's core duty of taking suitable action to improve the profession of pharmacy. As foreseen in the Pharmacy Act 2007 and to implement the recommendations contained in the interim report of the Pharmacy Ireland 2020 sub-committee of the PSI Council. In order to manage the implementation and on-going management of the CPD programme allied with the development of pharmacy services, the PSI requires the establishment of this Institute. It is also intended that the contract will include the appointment of an Institute Executive Director to manage the Institute overall and a Director of Pharmacy Practice Development to oversee the development of pharmacy services. Further details can be found in the expression of interest document on www.etenders.gov.ie. A copy of all above mentioned reports is available on the PSI website at www.pharmaceuticalsociety.ie. To register your interest in this notice and obtain any additional information please visit the eTenders web site at http://www.etenders.gov.ie/Search/Search_Switch.aspx?ID=171932.
The establishment of an Institute of Pharmacy managing body. The Pharmaceutical Society of Ireland ("PSI") is the statutory body established under the Pharmacy Act, 2007 charged with the regulation of the pharmacy sector in Ireland. It acts in the public interest to regulate the profession. A core function of the PSI includes the requirement to promote and ensure a high standard of education and training for persons seeking to become pharmacists and that those persons and pharmacists obtain appropriate experience and to ensure that pharmacists undertake appropriate continuing professional development, including the acquisition of specialisation. One of the PSI's main duties is the accreditation of education regimes for pharmacists, both prior to and post-registration. A further key duty is the requirement to take suitable action to improve the profession of pharmacy. PSI recently commissioned studies to review the 5 year programme of education and training required to qualify as a pharmacist and the associated accreditation system (in August 2008) and to review international Continuing Professional Development (CPD) models to determine an appropriate system of CPD for pharmacists in Ireland (in January 2009). The PSI now wishes to proceed with the implementation of these recommendations to ensure a competency based approach to development that extends across both pre-registration and ongoing registration systems. With regard to the latter, the CPD review recommends the establishment of "an Institute overseeing the management and delivery of CPD, funding and supporting appropriate provision and ensuring outcomes are generated by providers and assessing the practice standards of pharmacists". The Institute will also be required to contribute to the PSI's core duty of taking suitable action to improve the profession of pharmacy. As foreseen in the Pharmacy Act 2007 and to implement the recommendations contained in the interim report of the Pharmacy Ireland 2020 sub-committee of the PSI Council. In order to manage the implementation and on-going management of the CPD programme allied with the development of pharmacy services, the PSI requires the establishment of this Institute. It is also intended that the contract will include the appointment of an Institute Executive Director to manage the Institute overall and a Director of Pharmacy Practice Development to oversee the development of pharmacy services. Further details can be found in the expression of interest document on www.etenders.gov.ie. A copy of all above mentioned reports is available on the PSI website at www.pharmaceuticalsociety.ie. To register your interest in this notice and obtain any additional information please visit the eTenders web site at http://www.etenders.gov.ie/Search/Search_Switch.aspx?ID=171932.
Place of performance Dublin
🏙️ Notice metadata
Document type: Contract notice
Nature of contract: Service contract
Regulation: European Communities, with participation by GPA countries
Original language: English 🗣️
Procedure
Procedure type: Restricted procedure
Award criteria
The most economic tender
Type of bid: Global tender
Awarding authority type: Body governed by public law
Main activity: Health
Contracting authority Identity
Awarding authority name: The Pharmaceutical Society of Ireland
Country: Ireland 🇮🇪 Contact
Internet address: www.pharmaceuticalsociety.ie🌏